![Annie Vereecken](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Annie Vereecken
Gründer bei Heran Partners BVBA
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Joris Mortelmans | M | - |
Opdorp Finance BV
![]() Opdorp Finance BV Investment Trusts/Mutual FundsMiscellaneous Opdorp Finance BV operates as a finance industry. The private company is based in Antwerp, Belgium.
Heran Partners BVBA
![]() Heran Partners BVBA Investment ManagersFinance Heran Partners BVBA is a venture capital and private equity firm founded in 2020 by Annie Vereecken, Katleen Vandersmissen, Joris Mortelmans and Herman Verrelst. The firm is headquartered in Antwerp, Belgium. | 7 Jahre |
Olivier Lemaire | M | - |
Ziphius Vaccines NV
![]() Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
Herman Verrelst | M | 51 |
Heran Partners BVBA
![]() Heran Partners BVBA Investment ManagersFinance Heran Partners BVBA is a venture capital and private equity firm founded in 2020 by Annie Vereecken, Katleen Vandersmissen, Joris Mortelmans and Herman Verrelst. The firm is headquartered in Antwerp, Belgium.
Opdorp Finance BV
![]() Opdorp Finance BV Investment Trusts/Mutual FundsMiscellaneous Opdorp Finance BV operates as a finance industry. The private company is based in Antwerp, Belgium. | 4 Jahre |
Christian Cardon | M | 56 |
Ziphius Vaccines NV
![]() Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | 5 Jahre |
Wouter Uten | M | - |
UgenTec NV
![]() UgenTec NV Packaged SoftwareTechnology Services UgenTec NV develops laboratory software. The firm delivers an independent diagnostic platform to help molecular labs with DNA (PCR) analyses. The company was founded by Tom Martens and Wouter Uten on April 30, 2014 and is headquartered in Hasselt, Belgium. | 10 Jahre |
Gert Desmet | M | - |
PharmaFluidics NV
![]() PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium. | 14 Jahre |
Marie Bouillez | F | 43 |
PharmaFluidics NV
![]() PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium. | - |
Tom Martens | M | - |
UgenTec NV
![]() UgenTec NV Packaged SoftwareTechnology Services UgenTec NV develops laboratory software. The firm delivers an independent diagnostic platform to help molecular labs with DNA (PCR) analyses. The company was founded by Tom Martens and Wouter Uten on April 30, 2014 and is headquartered in Hasselt, Belgium. | 10 Jahre |
Fasha Mahjoor | M | - |
PharmaFluidics NV
![]() PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium. | - |
Johan Devenyns | M | - |
PharmaFluidics NV
![]() PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium. | - |
Katleen Vandersmissen | M | - |
Heran Partners BVBA
![]() Heran Partners BVBA Investment ManagersFinance Heran Partners BVBA is a venture capital and private equity firm founded in 2020 by Annie Vereecken, Katleen Vandersmissen, Joris Mortelmans and Herman Verrelst. The firm is headquartered in Antwerp, Belgium. | 4 Jahre |
Danny Gonnissen | M | - |
PharmaFluidics NV
![]() PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium. | - |
Tom Aerts | M | - |
UgenTec NV
![]() UgenTec NV Packaged SoftwareTechnology Services UgenTec NV develops laboratory software. The firm delivers an independent diagnostic platform to help molecular labs with DNA (PCR) analyses. The company was founded by Tom Martens and Wouter Uten on April 30, 2014 and is headquartered in Hasselt, Belgium. | - |
Ivo Marechal | M | 60 |
UgenTec NV
![]() UgenTec NV Packaged SoftwareTechnology Services UgenTec NV develops laboratory software. The firm delivers an independent diagnostic platform to help molecular labs with DNA (PCR) analyses. The company was founded by Tom Martens and Wouter Uten on April 30, 2014 and is headquartered in Hasselt, Belgium. | - |
Steven Verhoeven | M | - |
UgenTec NV
![]() UgenTec NV Packaged SoftwareTechnology Services UgenTec NV develops laboratory software. The firm delivers an independent diagnostic platform to help molecular labs with DNA (PCR) analyses. The company was founded by Tom Martens and Wouter Uten on April 30, 2014 and is headquartered in Hasselt, Belgium. | - |
Tom Almey | M | - |
Ziphius Vaccines NV
![]() Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
Michel Allé | M | 74 |
PharmaFluidics NV
![]() PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium. | - |
Geert Salembier | M | - |
MedHold NV
![]() MedHold NV Medical/Nursing ServicesHealth Services MedHold NV operates clinical laboratories. The company carries out medical analyses for human and veterinary purposes in Belgium and The Netherlands. The firm has laboratories in Antwerp, Lokeren, and Bruges. MedHold offers services in immunology, haematology, microbiology, anatomic pathology, molecular biology, radio isotopes, toxicology, and veterinary science and pathology. The firm was founded in 2007 and is headquartered in Antwerp, Belgium | - |
Dirk van Waes | M | - |
MedHold NV
![]() MedHold NV Medical/Nursing ServicesHealth Services MedHold NV operates clinical laboratories. The company carries out medical analyses for human and veterinary purposes in Belgium and The Netherlands. The firm has laboratories in Antwerp, Lokeren, and Bruges. MedHold offers services in immunology, haematology, microbiology, anatomic pathology, molecular biology, radio isotopes, toxicology, and veterinary science and pathology. The firm was founded in 2007 and is headquartered in Antwerp, Belgium | - |
Geoffrey Dhondt | M | - |
Heran Partners BVBA
![]() Heran Partners BVBA Investment ManagersFinance Heran Partners BVBA is a venture capital and private equity firm founded in 2020 by Annie Vereecken, Katleen Vandersmissen, Joris Mortelmans and Herman Verrelst. The firm is headquartered in Antwerp, Belgium. | 3 Jahre |
Johan Van Hoof | M | - |
Ziphius Vaccines NV
![]() Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
Griet Nuytinck | M | - |
Ziphius Vaccines NV
![]() Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then. | - |
Philippe Stas | M | - |
PharmaFluidics NV
![]() PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium. | - |
Pieter de Waele | M | - |
Laboratoria Wolfs NV
![]() Laboratoria Wolfs NV Pharmaceuticals: MajorHealth Technology Laboratoria Wolfs NV is a pharmaceutical and Belgian nutraceutical product manufacturing company founded in 1968. The private company is based in Zwijndrecht, Belgium. | - |
Rudi Mariën | M | 79 |
PharmaFluidics NV
![]() PharmaFluidics NV Electronic Equipment/InstrumentsElectronic Technology Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Belgien | 25 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Annie Vereecken
- Persönliches Netzwerk